oncolytic virusimmune checkpoint inhibitors
…ies (e.g. adoptive cell transfer, immune checkpoint inhibitors, oncolytic virus...) in oncology.Results Growth characteristics of human tumors …
10,506articles mentioning drugs
58,393drug mentions
9,496distinct drugs extracted
0%of mentions human-reviewed
All extracted drugs
Showing 721–780 of 9,496, ordered by supporting articles. Choose a drug to see its evidence.
Dapsone5Diclofenac5Epirubicin5FibroScan5Hyperbaric bupivacaine5ICB5ICS/LABA5IFNγ5IL-185SARS-CoV-25donanemab5immunomodulators5low-dose aspirin5tapentadol5thiazolidinediones56-mercaptopurine5High-dose steroids5JAK inhibitors5Letrozole5Mercaptopurine5Steroid5Trastuzumab Emtansine5Vitamin B125antiseizure medication5candesartan5ganciclovir5immune checkpoint inhibitor5non-steroidal anti-inflammatory drug5normal saline5nortriptyline5supplemental oxygen5ASMs5Atracurium5Bacillus Calmette-Guérin5Bendamustine5High-dose intravenous methylprednisolone5SF-365Selective Serotonin Reuptake Inhibitors5acetic acid5contraceptives5delpar5intravenous ceftriaxone5liposomal amphotericin B5prescription opioids5topical corticosteroids5venlafaxine5DPP4i4ELA4Estrogen4Rilvegostomig4HM163904Alectinib4Penumbra4RP14LEvoSimendan4Nipocalimab4Dinutuximab4SEL4BLM4IL-17i4
Articles mentioning drugs
10,506 articles · page 569 of 876Pembrolizumabenfortumab vedotinECOG Performance StatusDana-Farber Cancer Instituteurothelialbreast
…types were urothelial (n=307; 53.9%) and breast (n=125; 21.9%). Pembrolizumab (n=386; 67.7%) and enfortumab vedotin (n=291; 51.1%) were the m…
cisplatincisplatin-inducedhigh-grade serous ovarian cancer (HGSOC)HGSOC
… analyzed to identify immune-modulatory factors associated with cisplatin (DDP) resistance. The effects of DDP on Galectin-9 (Gal-9) expr…
MagrolimabBsAbGemPharmatech
… was used to assess anti-tumor efficacy of anti-hCD47 antibody (Magrolimab (5F9)) in a CT26-hCD47 (CT26 cells overexpressing human CD47) c…
ipilimumabnivolumabmelanomametastatic melanomamelanoma brain metastasesMBM
…ng of brain metastases in relation to outcome during first-line ipilimumab plus nivolumab therapy for metastatic melanoma in a community o…
bintrafusp alfaHPV-associated malignanciesimmunotherapyNCT03427411
…ycles of administration of a dual inhibitor of PD-L1 and TGF-β, bintrafusp alfa, in 51 patients with HPV16/18-associated cancers ( NCT03427411)…
ICIsColorectal cancerCRCCancer immunotherapyAryastha Bio Solutions
…ogous or allogeneic immune cells (PBMCs, TILs) and treated with ICIs—alone or combined with drugs identified via in silico modeling …
Pembrolizumabnivolumabstage IIB/C melanomastage IIB/IIC melanomaFDAadjuvant immunotherapystage IIB/C disease
…(11):2835–2843. doi: 10.1038/s41591-023-02583-2.Luke JJ, et al, Pembrolizumab versus placebo as adjuvant therapy in completely resected stage…
iNeo-Vac-R01Zhejiang University School of MedicineSir Run Run Shaw Hospitalpancreatic cancergastric cancercholangiocarcinomaesophageal canceradvanced digestive system malignancies
…al prognosis and urgently require effective salvage treatments. iNeo-Vac-R01, a novel personalized neoantigen-based mRNA cancer vaccine, was…
ERVE-4ccRCCJ Clin Invest
…tic ccRCC.Methods Fifteen patients received escalating doses of ERVE-4 T-cells (1, 5, 10, and 50 x 10^6 cells/kg) in a 3+3 design. TCR…
ICICareggi University HospitalmNSCLCmetastatic non-small-cell carcinoma
…Background Single-agent immune checkpoint inhibitors (ICI) is the standard treatment for patients with metastatic non-sma…
nivolumabCTONG1104Bristol-Myers Squibbneoadjuvant immunotherapyEGFR-mutant NSCLCchemotherapy
…ze the TCR sequence associated with the efficacy of neoadjuvant nivolumab and confirm their belonging T cell subsets.Results Among them, …